TFA Therapeutics, Inc. (RAJAF) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$141.1K | +23.3% |
| 2024 | -$183.9K | -180.7% |
| 2023 | $227.8K | +154.9% |
| 2022 | -$415.1K | -247.7% |
| 2021 | -$119.4K | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$141.1K | +23.3% |
| 2024 | -$183.9K | -180.7% |
| 2023 | $227.8K | +154.9% |
| 2022 | -$415.1K | -247.7% |
| 2021 | -$119.4K | — |